Source: Health Products Regulatory Authority (ZA) Revision Year: 2013 Publisher: GlaxoSmithKline South Africa (Pty) Ltd, 39 Hawkins Avenue, Epping Industria 1, 7460
CLINDOXYL Gel.
| Pharmaceutical Form |
|---|
|
Gel. A white to slightly yellow homogenous gel. |
Each 100 g contains: Clindamycin phosphate equivalent to clindamycin 1,00 g and hydrous benzoyl peroxide equivalent to anhydrous benzoyl peroxide 5,00 g.
| Active Ingredient | Description | |
|---|---|---|
| Benzoyl peroxide |
Benzoyl peroxide is a highly lipophilic, oxidising agent with keratolytic and bacteriocidal effects. The effectiveness of benzoyl peroxide in the treatment of acne vulgaris is primarily attributable to its antibacterial activity, especially with respect to Propionibacterium acnes. Benzoyl peroxide is also believed to be effective in the treatment of acne on account of its anti-inflammatory and mild keratolytic properties. |
|
| Clindamycin |
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
| List of Excipients |
|---|
|
|
Membrane-sealed aluminium tubes fitted with a white polyethylene screw cap containing 25 g of gel presented in a carton.
GlaxoSmithKline South Africa (Pty) Ltd, 39 Hawkins Avenue, Epping Industria 1, 7460
42/13.11/0441
| Drug | Countries | |
|---|---|---|
| CLINDOXYL | Brazil, Canada, Finland, Singapore, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
